D.G. Meuleman

1.8k citations

29 papers · 1.4k indexed · h-index 16

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments

Papers in

Hematology 19
- Blood Coagulation and Thrombosis Mechanisms 13
- Platelet Disorders and Treatments 12
Cell Biology 14
- Proteoglycans and glycosaminoglycans research 14

Co-authors: G.M.T. Vogel Paul M.J. Hobbelen Maurice Petitou Éva Bíró Rienk Nieuwland C. A. A. VAN BOECKEL R.G.M. van Amsterdam Martine J. Smit
Journals: Thrombosis Research (8 papers)Blood (5 papers)Thrombosis and Haemostasis (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Thrombosis and Haemostasis (2 papers)
Partner nations: Netherlands France Australia

In The Last Decade

D.G. Meuleman

28 papers receiving 1.3k citations

Peers

Countries citing papers authored by D.G. Meuleman

Since Specialization

Citations

This map shows the geographic impact of D.G. Meuleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.G. Meuleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.G. Meuleman more than expected).

Fields of papers citing papers by D.G. Meuleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.G. Meuleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.G. Meuleman. The network helps show where D.G. Meuleman may publish in the future.

Co-authors

The 25 scholars most cited alongside D.G. Meuleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D.G. Meuleman Line = papers co-authored together D.G. Meuleman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties Thrombosis Research ·刘凤芸, A.N. Böing, Éva Bíró, Frans J. Hoek, G.M.T. Vogel, D.G. Meuleman, A. Sturk, Rienk Nieuwland	2007	84
2	Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin Blood ·Pierre Savi, Beng H. Chong, Andreas Greinacher, Yves Gruel, John G. Kelton, Theodore E. Warkentin, Petra Eichler, D.G. Meuleman, Maurice Petitou, Jean-Pascal Hérault, R Cariou, Jean‐Marc Herbert	2004	151
3	Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner Journal of Thrombosis and Haemostasis ·Éva Bíró, Aurelia Andreea SCARLAT, G.M.T. Vogel, D.G. Meuleman, Martine J. Smit, C. Erik Hack, Auguste Sturk, Rienk Nieuwland	2003	248
4	Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity Journal of Thrombosis and Haemostasis ·G.M.T. Vogel, D.G. Meuleman, Magda Abbas, Rogier C. Buijsman, Karen L Olson, Martine J. Smit	2003	15
5	Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide Blood ·J. M. Herbert, Jean-P. Hérault, A. Bernat, R.G.M. van Amsterdam, J C Lormeau, Maurice Petitou, Cécile Daumas, Peter Hoffmann, D.G. Meuleman	1998	5
6	Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide Blood ·J. M. Herbert, Jean-P. Hérault, A. Bernat, R.G.M. van Amsterdam, J C Lormeau, Maurice Petitou, Cécile Daumas, Peter Hoffmann, D.G. Meuleman	1998	159
7	SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent Cardiovascular Drug Reviews ·J. M. Herbert, Maurice Petitou, J C Lormeau, R Cariou, J Necciari, Harry N. Magnani, Pieter Zandberg, R.G.M. van Amsterdam, C. A. A. VAN BOECKEL, D.G. Meuleman	1997	76
8	Biochemical and Pharmacological Properties of SANORG 32701 Circulation Research ·Jean‐Marc Herbert, Николенко Александр Александрович, A. Bernat, R.G.M. van Amsterdam, G.M.T. Vogel, J C Lormeau, Maurice Petitou, D.G. Meuleman	1996	63
9	Glycosaminoglycans: Synthetic fragments and their interaction with serine protease inhibitors Pure and Applied Chemistry ·C. A. A. VAN BOECKEL, Peter D. J. Grootenhuis, D.G. Meuleman, Pieter Westerduin	1995	13
10	Feasible synthesis and biological properties of six ‘non-glycosamino’ glycan analogues of the antithrombin III binding heparin pentasaccharide Bioorganic & Medicinal Chemistry ·Pieter Westerduin, C. A. A. VAN BOECKEL, Jan E. M. Basten, Nikol Alexander-Floyd, Hans Lucas, Lizeth Plata, Harry van der Heijden, R.G.M. van Amsterdam, Katia Ippaso, D.G. Meuleman, Arie Visser, G.M.T. Vogel, Jan B. L. DAMM, Fukushima Shun-ichi	1994	61
11	Orgaran (Org 10172): Its Pharmacological Profile in Experimental Models Pathophysiology of Haemostasis and Thrombosis ·D.G. Meuleman	1992	76
12	Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide. PubMed ·D.G. Meuleman, Paul M.J. Hobbelen, Magda Abbas, G.M.T. Vogel, C. A. A. VAN BOECKEL, Museo Nacional de Bellas Artes	1991	15
13	Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans Thrombosis Research ·Arie Visser, D.G. Meuleman	1990	8
14	Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans Thrombosis Research ·G.M.T. Vogel, D.G. Meuleman, S. Yuwono, Paul M.J. Hobbelen	1989	89
15	Structure‐Activity Relationships of Synthetic Heparin Fragments Annals of the New York Academy of Sciences ·C. A. A. VAN BOECKEL, S. F. VAN AELST, T. Beetz, D.G. Meuleman, E. C. Van Woerkens, Museo Nacional de Bellas Artes	1989	13
16	Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of iow molecular weight heparinoid Org 10172 or heparin to rats Thrombosis Research ·Paul M.J. Hobbelen, G.M.T. Vogel, D.G. Meuleman	1987	30
17	Placental transfer of org 10172, a low-molecular weight heparinoid, in the awake late-pregnant guinea pig Thrombosis Research ·Louis L.H. Peeters, Paul M.J. Hobbelen, Caroline Warpechowski Lazaroto, G.M.T. Vogel, A M Carlos González, D.G. Meuleman, Henk C.S. Wallenburg	1986	13
18	Effects of intra-arterial cannulation on blood platelet consumption in rats Thrombosis Research ·D.G. Meuleman, G.M.T. Vogel, A.M.L. van Delft	1980	16
19	Normalization of Platelet Survival in an Experimental Model after Platelet Exposure of Thrombin in Vitro or adp in Vivo Thrombosis and Haemostasis ·D.G. Meuleman, Michael R. Buchanan, Alan R. Giles, J. Hirsh	1977	1
20	Reduction of Platelet Survival: Development of a Thrombosis Model Thrombosis and Haemostasis ·D.G. Meuleman	1975	2

About D.G. Meuleman

D.G. Meuleman is a scholar working on Hematology, Cell Biology, Internal Medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (14 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers), Platelet Disorders and Treatments (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Carbohydrate Chemistry and Synthesis (6 papers), Blood properties and coagulation (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Internal Medicine (513 citations), Hematology (555 citations), Cardiology and Cardiovascular Medicine (397 citations), Cell Biology (253 citations) and Emergency Medicine (104 citations). D.G. Meuleman has collaborated with scholars based in Netherlands, France and Australia. Frequent co-authors include G.M.T. Vogel, Paul M.J. Hobbelen, Maurice Petitou, Éva Bíró, Rienk Nieuwland, C. A. A. VAN BOECKEL, G.M.T. Vogel, R.G.M. van Amsterdam, Martine J. Smit and J C Lormeau. Their work appears in journals such as Thrombosis Research, Blood, Thrombosis and Haemostasis, Journal of Medicinal Chemistry and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact